You cannot select more than 25 topics
Topics must start with a letter or number, can include dashes ('-') and can be up to 35 characters long.
965 B
965 B
2024/10/30
- **Título**: Fixed dose albenzadole/ivermectin coformulation, an innovative tool to help countries achieve their NTD control goals in a post-donation era
- **Description**: The fixed-dose coformulation of albendazole and ivermectin is the result of 10+ years of innovations carried out by African and European organizations working through public-private partnerships.
This orodispersible, mango-flavoured tablet has already demonstrated safety and efficacy against soil-transmitted helminths in a pivotal trial, although its potential uses go beyond these parasites.
The fixed-dose combination of albendazole and ivermectin provides a novel approach to mass drug administration campaigns that simplifies logistics while providing better efficacy against more species of helminths.
While the frequently used albendazole 400mg monotherapy barely manages to reduce the prevalence of *Trichuris trichiura*, combining it with ivermectin